NCT03808233 is a clinical trial of ACTIVE mini in Spinal Muscular Atrophy, sponsored by University of Texas Southwestern Medical Center.

Who is sponsoring NCT03808233?

NCT03808233 is sponsored by University of Texas Southwestern Medical Center.

What drugs are being tested in NCT03808233?

Interventions in NCT03808233: ACTIVE mini.

What condition does NCT03808233 study?

NCT03808233 studies Spinal Muscular Atrophy.

Is NCT03808233 still recruiting?

NCT03808233 is currently completed. Last updated 17 January 2019.

Last reviewed 2019-01-17 · How we verify

NCT03808233

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Reliability and Validity of the ACTIVE-mini for Quantifying Movement in Infants With Spinal Muscular Atrophy

Completed Last updated 17 January 2019

What this trial tests

trial testing ACTIVE mini in Spinal Muscular Atrophy in 25 participants. Completed in 31 August 2018.

Timeline

5 November 2016

Primary endpoint
1 June 2018

31 August 2018

Quick facts

Lead sponsor	University of Texas Southwestern Medical Center
Status	Completed
Study type	OBSERVATIONAL
Enrollment	25
Start date	5 November 2016
Primary completion	1 June 2018
Estimated completion	31 August 2018

Drugs / interventions tested

ACTIVE mini

Conditions studied

Spinal Muscular Atrophy — all drugs for Spinal Muscular Atrophy →

Sponsor

University of Texas Southwestern Medical Center

Who can join

Eligibility, any sex, with Spinal Muscular Atrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the measurement properties of the Ability Captured Through Interactive Video Evaluation-mini (ACTIVE-mini) for quantifying movement in infants with Spinal Muscular Atrophy (SMA). Specifically, I will investigate within-day and between-day test-retest reliability and calculate the minimal detectable change of the ACTIVE-mini. Additionally, I will determine the concurrent validity of the ACTIVE-mini with The Children's Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP INTEND) and the construct validity of the ACTIVE-mini in infants with SMA using a known group methodology.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Spinal Muscular Atrophy

Currently open trials in the same condition.

NCT07478172 — Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease · NA · recruiting
NCT06955897 — Characterizing Perceived Physical Fatigability in Nusinersen-treated SMA · recruiting
NCT06396325 — A Registry Based Randomized-Controlled Trial of an Upper Limb Exergaming Intervention for Children and Adolescents With · NA · recruiting
NCT06288230 — An Open Label Study of Gene Therapy Product (Vesemnogene Lantuparvovec) in Spinal Muscular Atrophy · Phase 1, PHASE2 · recruiting
NCT06321965 — Characterization of New Phenotypes of Patients With Spinal Muscular Atrophy Treated With SMN Restoring Therapy · NA · recruiting

Other University of Texas Southwestern Medical Center trials

Trials by the same sponsor.

NCT03849963 — Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain · recruiting
NCT06917183 — Developing Strategies for Implementation and Use of the Operating Room Black Box (ORBB) · NA · not yet recruiting
NCT05145309 — Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans · Phase 2 · not yet recruiting
NCT06552000 — Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer · NA · not yet recruiting
NCT07387666 — Imaging Acetadote Metabolism in Glioblastoma · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03808233 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Texas Southwestern Medical Center
Last refreshed: 17 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03808233.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing